Your browser doesn't support javascript.
loading
A Multicenter Phase 2 Clinical Trial of 10-Day Decitabine, Dose-Escalated Donor Lymphocyte Infusion, and Ruxolitinib for Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes after Allogeneic Hematopoietic Cell Transplantation.
Rashidi, Armin; Huselton, Eric J; Stefanski, Heather E; DeFor, Todd E; Shanley, Ryan; Choi, Jaebok; DiPersio, John F; Juckett, Mark; Miller, Jeffrey S; Weisdorf, Daniel J; Schroeder, Mark A.
Afiliação
  • Rashidi A; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota; Clinical Research Division, Fred Hutchinson Cancer Center and Division of Oncology, University of Washington, Seattle, Washington. Electronic address: arashidi@fredhutch.org
  • Huselton EJ; Division of Hematology and Oncology, University of Rochester, Rochester, New York.
  • Stefanski HE; Division of Blood and Marrow Transplantation, Department of Pediatrics, University of Minnesota, Minneapolis, Minnesota.
  • DeFor TE; Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
  • Shanley R; Biostatistics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, Minnesota.
  • Choi J; Division of Oncology, Washington University School of Medicine in St Louis, St Louis, Missouri.
  • DiPersio JF; Division of Oncology, Washington University School of Medicine in St Louis, St Louis, Missouri.
  • Juckett M; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Miller JS; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Weisdorf DJ; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota.
  • Schroeder MA; Division of Oncology, Washington University School of Medicine in St Louis, St Louis, Missouri.
Transplant Cell Ther ; 29(5): 328.e1-328.e6, 2023 05.
Article em En | MEDLINE | ID: mdl-36804933
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Clinical_trials / Etiology_studies Limite: Humans Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mieloide Aguda / Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro Tipo de estudo: Clinical_trials / Etiology_studies Limite: Humans Idioma: En Revista: Transplant Cell Ther Ano de publicação: 2023 Tipo de documento: Article